PROFライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:21):

Stats
本日の出来高	49 438.00
平均出来高	35 624.00
時価総額	191.93M
EPS	$0 ( 2024-03-07 )
次の収益日	( $-0.310 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.82
ATR14	$0.0860 (1.09%)

Insider Trading

Date	Person	Action	Amount	type
2012-12-20	Hofer Michael	Sell	40 000	Patriot Minefinders Inc.
2012-12-18	Hofer Michael	Sell	40 000	Patriot Minefinders Inc.
2012-06-19	Tejada Fred	Buy	500 000	Common Shares
2012-06-19	Blanchet Justin	Buy	500 000	Common Shares
2012-06-19	Schweitzer John H.	Buy	500 000	Common Shares

INSIDER POWER
0.00
Last 8 transactions
Buy: 3 000 000 \| Sell: 80 000

ボリューム相関

長: -0.11 (neutral)

短: -0.95 (very strong negative)

Signal:(52.165) Neutral

Profound Medical Corp 相関

10 最も正の相関
MOMO	0.966
IMVT	0.958
BRAC	0.957
GLRE	0.957
FXCO	0.956
FMIV	0.955
MLCO	0.954
CBAY	0.953
ALXN	0.951
AVAC	0.951

10 最も負の相関
PIII	-0.958
APOP	-0.953
SNPX	-0.949
GRIN	-0.947
CREG	-0.947
SWAV	-0.946
UTME	-0.945
OP	-0.944
SMIT	-0.944
LGMK	-0.941

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Profound Medical Corp 相関 - 通貨/商品

0.05
( neutral )

-0.05
( neutral )

0.00
( neutral )

-0.13
( neutral )

-0.12
( neutral )

0.10
( neutral )

Profound Medical Corp 財務諸表

Annual	2023
収益:	$7.33M
総利益:	$4.46M (60.87 %)
EPS:	$-1.370

FY	2023
収益:	$7.33M
総利益:	$4.46M (60.87 %)
EPS:	$-1.370

FY	2022
収益:	$6.68M
総利益:	$3.02M (45.22 %)
EPS:	$-1.380

FY	2021
収益:	$6.87M
総利益:	$2.95M (42.95 %)
EPS:	$-1.500

Financial Reports:

No articles found.

Profound Medical Corp

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. is headquartered in Mississauga, Canada.